People with thyroid cancer who develop hypoparathyroidism after surgery have reduced quality of life and worse symptoms than those without hypoparathyroidism, a study reports. The study, “Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer” was published in The Journal of Clinical Endocrinology &…
News
Same But Different, a nonprofit U.K. group that uses art for social change, is inviting people to choose their favorite photographs in a calendar contest to heighten awareness of rare diseases, including amyotrophic lateral sclerosis (ALS). The organization’s panel of judges has pared the number of contest submissions…
Ascendis Pharma‘s TransCon PTH can safely treat hypoparathyroidism, reducing the need for other therapies and improving patients’ quality of life, an extension period of the PaTH Forward Phase 2 trial shows. “Today we announced preliminary clinical results which demonstrate that TransCon PTH can potentially…
Calcium deposits in the carotid arteries and brain are more common in people with permanent hypoparathyroidism who underwent thyroid removal surgery than in the general population, a study reports. As such, calcifications should be monitored in this patient population, researchers said.
Having a greater than 65% drop in parathyroid hormone (PTH) levels on the first day after a total thyroid removal increases the likelihood of developing transient calcium deficiency, or hypocalcemia, according to a single-center study in China. People with hypocalcemia have lower than normal levels in their blood…
TransCon PTH, an investigational therapy being developed by Ascendis Pharma, safely normalized calcium and phosphate levels, and reduced the need for other treatments in adults with hypoparathyroidism, data from the PaTH Forward Phase 2 trial demonstrate. The data were presented by Ascendis…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme “A Glimmer of Hope,” the competition is a means to “visually express the hope that exists for people affected by…
A novel approach for the production of parathyroid-like cells from stem cells — cells from which all others with specialized functions are generated — could help find new treatments for hypoparathyroidism, a study suggests. The study, “Differentiation of parathyroid hormone expressing cells from human pluripotent…
The International Osteoporosis Foundation (IOF) recently launched Skeletal Rare Diseases Academy, recognizing two researchers with awards for their work in hypoparathyroidism-associated bone changes and pregnancy outcomes. The awards, intended to recognize research excellence among young scientists in the field of rare bone disorders, were announced recently during…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the search for new medicines for rare disorders and incorporating more patient input into research. The goal is to help the pharmaceutical industry deliver innovative new therapies faster and smarter, the…
Recent Posts
- New weekly therapy moves toward Phase 3 for hypoparathyroidism
- My PATTH with hypoparathyroidism is unknown, but my purpose is clear
- As Tatum’s return from injury shows, a comeback is better than a setback
- Calcium, vitamin D supplements key after thyroid surgery, per study
- An at-home calcium tester is in development — and I’m celebrating!